Search results
As states loosen childhood vaccine requirements, health experts’ worries grow
KPVI· 10 hours agoOn the heels of the COVID-19 pandemic and with growing skepticism around vaccinations and government...
Signs of rising COVID in California as new FLiRT subvariants dominate
LA Times via Yahoo News· 5 days agoCalifornia may be headed to an earlier start to the summer COVID-19 season than normal as the latest...
Whooping cough outbreaks: Why is pertussis on the rise in several countries?
LiveScience· 2 days agoCases of whooping cough, or pertussis, have been on the rise in various countries, including the...
Oregon reports 770% spike in whooping cough cases as vaccination rates keep falling
The Register-Guard via Yahoo News· 41 minutes agoRisk, hospitalization, and vaccines Pertussis is more severe for infants, pregnant people, young children, and individuals...Oregon Health Authority reveals between 2003 and ...
More than 90% of chickenpox cases in New York City outbreak among unvaccinated people
ABC News via Yahoo News· 4 hours agoNearly all the patients affected by an ongoing chickenpox outbreak in New York City are...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 4 days agoIts late-stage pipeline is exciting. The company is running phase 3 studies for a combination COVID...
Oregon health officials report sharp increase in whooping cough cases
KGW NewsChannel 8 Portland· 5 hours agoAs of May 29, 178 cases have been reported to the Oregon Health Authority — a 770% increase compared...
Valneva (NASDAQ:VALN) Trading 6% Higher
ETF DAILY NEWS· 6 days agoValneva SE (NASDAQ:VALN – Get Free Report) shares were up 6% during trading on Wednesday . The company traded as high as $8.69 and last traded at $8.69. Approximately 913 shares traded hands ...
Chase Oliver: What does the Libertarian presidential candidate really believe?
Reason.com· 3 hours agoOn Just Asking Questions, the Libertarian presidential candidate clarifies his views amid criticisms...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 12 hours agoThe biopharma company has also used a lot of the cash made when COVID-19 was a more serious concern to gobble up smaller drugmakers. Since 2022, Pfizer...
